New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
LB Pharmaceuticals Inc (LBRX) vs Taysha Gene Therapies, Inc. (TSHA)
- LB Pharmaceuticals Inc LBRX 38.90 −2.80%
- Taysha Gene Therapies, Inc. TSHA 3.71 −1.59%
LB Pharmaceuticals Inc and Taysha Gene Therapies, Inc. are both Biotechnology companies. LB Pharmaceuticals Inc and Taysha Gene Therapies, Inc. are of similar size ($1.3B and $1.3B). Across the 10 metrics below, LB Pharmaceuticals Inc leads on 5 and Taysha Gene Therapies, Inc. on 5.
Valuation
Profitability
| Metric | LBRX | TSHA | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 100.00% | 70.18% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (38.80%) | (54.18%) | (51.58%) |
| Return on assets | (36.48%) | (41.52%) | (45.91%) |
| Return on invested capital | (686.18%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack